Cargando…
Use, tolerability and compliance of spironolactone in the treatment of heart failure
BACKGROUND: Risk of morbidity and mortality in patients with severe heart failure (HF) is reduced by blockade of aldosterone receptors with spironolactone. However, benefits of spironolactone are potentially limited by treatment compliance and adverse events profile. The aim of this study was to est...
Autores principales: | Lachaine, Jean, Beauchemin, Catherine, Ramos, Elodie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121672/ https://www.ncbi.nlm.nih.gov/pubmed/21599961 http://dx.doi.org/10.1186/1472-6904-11-4 |
Ejemplares similares
-
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020) -
Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022) -
Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020) -
Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2022) -
Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute
Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)